Literature DB >> 23689082

Colorectal cancer: Is the new era of colorectal cancer classification finally here?

Iris D Nagtegaal, J Han J M van Krieken.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23689082     DOI： 10.1038/nrgastro.2013.90

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN： 1759-5045            Impact factor:   46.802


× No keyword cloud information.
  9 in total

1.  Biomarkers as disease definition: mantle cell lymphoma as an example.

Authors:  Johan H J M van Krieken; Corine Jansen; Konnie M Hebeda; Patricia J T A Groenen
Journal:  Proteomics Clin Appl       Date:  2010-12       Impact factor: 3.494

Review 2.  Microsatellite instability as a marker of prognosis and response to therapy: a meta-analysis of colorectal cancer survival data.

Authors:  Cecilia Guastadisegni; Mauro Colafranceschi; Laura Ottini; Eugenia Dogliotti
Journal:  Eur J Cancer       Date:  2010-06-04       Impact factor: 9.162

3.  Molecular patterns in the evolution of serrated lesion of the colorectum.

Authors:  Timo Gaiser; Sandra Meinhardt; Daniela Hirsch; Jonathan Keith Killian; Jochen Gaedcke; Peter Jo; Immaculada Ponsa; Rosa Miró; Josef Rüschoff; Gerhard Seitz; Yue Hu; Jordi Camps; Thomas Ried
Journal:  Int J Cancer       Date:  2012-10-17       Impact factor: 7.396

Review 4.  ZEB/miR-200 feedback loop: at the crossroads of signal transduction in cancer.

Authors:  Louise Hill; Gareth Browne; Eugene Tulchinsky
Journal:  Int J Cancer       Date:  2012-07-21       Impact factor: 7.396

5.  CDX2, a highly sensitive and specific marker of adenocarcinomas of intestinal origin: an immunohistochemical survey of 476 primary and metastatic carcinomas.

Authors:  Robert W Werling; Hadi Yaziji; Carlos E Bacchi; Allen M Gown
Journal:  Am J Surg Pathol       Date:  2003-03       Impact factor: 6.394

6.  A colorectal cancer classification system that associates cellular phenotype and responses to therapy.

Authors:  Anguraj Sadanandam; Costas A Lyssiotis; Krisztian Homicsko; Eric A Collisson; William J Gibb; Stephan Wullschleger; Liliane C Gonzalez Ostos; William A Lannon; Carsten Grotzinger; Maguy Del Rio; Benoit Lhermitte; Adam B Olshen; Bertram Wiedenmann; Lewis C Cantley; Joe W Gray; Douglas Hanahan
Journal:  Nat Med       Date:  2013-04-14       Impact factor: 53.440

7.  Poor-prognosis colon cancer is defined by a molecularly distinct subtype and develops from serrated precursor lesions.

Authors:  Felipe De Sousa E Melo; Xin Wang; Marnix Jansen; Evelyn Fessler; Anne Trinh; Laura P M H de Rooij; Joan H de Jong; Onno J de Boer; Ronald van Leersum; Maarten F Bijlsma; Hans Rodermond; Maartje van der Heijden; Carel J M van Noesel; Jurriaan B Tuynman; Evelien Dekker; Florian Markowetz; Jan Paul Medema; Louis Vermeulen
Journal:  Nat Med       Date:  2013-04-14       Impact factor: 53.440

Review 8.  American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer.

Authors:  Al B Benson; Deborah Schrag; Mark R Somerfield; Alfred M Cohen; Alvaro T Figueredo; Patrick J Flynn; Monika K Krzyzanowska; Jean Maroun; Pamela McAllister; Eric Van Cutsem; Melissa Brouwers; Manya Charette; Daniel G Haller
Journal:  J Clin Oncol       Date:  2004-06-15       Impact factor: 44.544

9.  Loss of membranous Ep-CAM in budding colorectal carcinoma cells.

Authors:  Marleen J E M Gosens; Léon C L van Kempen; Cornelis J H van de Velde; J Han J M van Krieken; Iris D Nagtegaal
Journal:  Mod Pathol       Date:  2007-02       Impact factor: 7.842
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.